Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane‐Containing Chemotherapy
Authors:
- Nanae HorisawaNHNanae Horisawa
- Akiyo YoshimuraAYAkiyo Yoshimura
- Isao OzeIOIsao Oze
- Masataka SawakiMSMasataka Sawaki
- Masaya HattoriMHMasaya Hattori
- Haruru KotaniHKHaruru Kotani
- Ayumi KataokaAKAyumi Kataoka
- Yuri OzakiYOYuri Ozaki
- Kazuki NozawaKNKazuki Nozawa
- Yuka EndoYEYuka Endo
- Daiki TakatsukaDTDaiki Takatsuka
- Ayaka IsogaiAIAyaka Isogai
Open Access
- 1 January 2024
- journal article
- research article
- Published by Wiley in The Breast Journal
- Vol. 2024 (1) , 3250143
Abstract
Purpose. Breast cancer‐related lymphedema (LE) significantly impairs the patients’ quality of life. Axillary lymph node dissection (ALND) is a strong risk factor for LE in breast cancer surgery. In addition, postoperative administration of docetaxel (DTX) has been reported to be a risk factor for LE in patients who undergo ALND. Herein, we performed the risk of objective LE after ALND. Methods. Patients who visited the medical follow‐up clinic between 12 November 2018 and 11 January 2019 and at least one year postoperatively were eligible for this study. The risk factors for objective LE according to taxane‐containing regimen, radiation therapy, and body mass index and the effects of a taxane‐containing regimen followed by supraclavicular irradiation on LE were examined. Results. A total of 214 patients were included in this analysis, and objective LE was observed in 52 patients (24%). Univariate and multivariate analyses showed that only supraclavicular field irradiation was a statistically significant risk factor for objective LE. In addition, the sequential use of taxane‐containing regimens and supraclavicular RT was shown to be a more likely risk factor for LE than ALND alone. We also compared each taxane regimen with supraclavicular RT and found that DTX was more likely to be a risk factor for LE in cases of sequential use of supraclavicular RT than with ALND alone. However, when comparing DTX with supraclavicular RT and PTX with supraclavicular RT directly, there was no statistically significant difference in the risk of objective LE between the two groups. Conclusion. The risk for LE was more likely to be higher with the sequential use of taxane‐containing chemotherapy and supraclavicular field irradiation. Therefore, management of LE is important in these cases.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot studyBreast Cancer, 2022
- Risk factors for breast cancer-related lymphedema: correlation with docetaxel administrationBreast Cancer, 2020
- Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivorsBreast Cancer Research and Treatment, 2019
- The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort studyBreast Cancer, 2018
- Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysisBreast Cancer Research and Treatment, 2016
- Adjuvant taxanes and the development of breast cancer-related arm lymphoedemaBritish Journal of Surgery, 2015
- Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohortBreast Cancer Research and Treatment, 2015
- Upper‐body morbidity after breast cancerCancer, 2012
- Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedemaSupportive Care in Cancer, 2005
- Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-upBreast Cancer Research and Treatment, 2005